Refine your search
Collections
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Thanikachalam, P.
- Assessment of Proliferative Index and its Association with Ki-67 Antigen Molecule Expression in Nodular Hyperplasia of Prostate
Abstract Views :2035 |
PDF Views:99
Authors
Srikumar Chakravarthi
1,
P. Thanikachalam
1,
H. S. Nagaraja
2,
David Low Wee Yang
3,
Nadeem Irfan Bukhari
3
Affiliations
1 Department of Pathology, International Medical University, Bukit Jalil, 57000 Kuala Lumpur, MY
2 Department of Physiology, Faculty of Medicine, International Medical University, Bukit Jalil, 57000 Kuala Lumpur, MY
3 Faculty of Pharmacy; International Medical University, Bukit Jalil, 57000 Kuala Lumpur, MY
1 Department of Pathology, International Medical University, Bukit Jalil, 57000 Kuala Lumpur, MY
2 Department of Physiology, Faculty of Medicine, International Medical University, Bukit Jalil, 57000 Kuala Lumpur, MY
3 Faculty of Pharmacy; International Medical University, Bukit Jalil, 57000 Kuala Lumpur, MY
Source
Indian Journal of Science and Technology, Vol 2, No 8 (2009), Pagination: 1-4Abstract
The cytoplasmic expression of Ki-67, a nuclear protein that appears primarily during the proliferative phases of the cell cycle was studied in benign tumours of the prostate gland. Archival prostatic tissue from 39 patients with nodular hyperplasia and no prior or subsequent prostatic carcinoma that have been obtained through transurethral prostatectomy (TURP) procedure, were used in this study. The proliferative index was assessed by calculating the number of actively proliferating cells in the H&E sections in varied histologic patterns like hyperplastic epithelium, proliferating stroma, normal glands and normal stroma. The nuclear protein Ki- 67 was analyzed by immunohistochemistry for determining the cytoplasmic positivity of the tumour cells. The proliferative index in the hyperplastic tissues was higher, indicating an increased activity of cellular proliferation, compared with the normal tissues, which was highly significant (p<0.01). Out of 39 cases of prostatic tissue, 25 (64 %) showed positivity for Ki-67 expression. Pearson's correlation test was applied to and showed significant association (p<0.05) between the intensity of Ki-67 expression with proliferative index. Comparisons of proliferative indices between the normal cells and tumour cells showed significant correlation, strongly suggesting the higher cell proliferation in the benign lesions. Enhanced expression of Ki-67 by the tumour cells suggests a growth imbalance in favour of cell proliferation that might ultimately promote prostatic hyperplasia.Keywords
Prostate, Mitosis, Ki-67, Nodular HyperplasiaFull Text
References
- Barry MJ and O'Leary MP (1995) Advances in benign prostatic hyperplasia: The developmental and clinical utility of symptom scores. Urol. Clin. North Am. 22(2), 299-307.
- Jacobson M, Weil M and Raff MC (1997) Programmed cell death in animal development. Cell. 88, 347–354.
- Jefferson KP, Persad RA and Holly JMP (2000) Apoptosis and its relevant to urologist. BJU International. 86, 598-606.
- Key G, Kubbutat MH and Gerdes J (1994) Assessment of cell proliferation by means of an enzyme- linked immunosorbent assay based on the detection of the Ki-67 protein. J. Immunol. Methods. 28, 177(1-2), 113-117.
- Kyprianou N, Tu HC and Stephen C (1996) Apoptotic versus proliferative activities in human benign prostatic hyperplasia. Human Pathology. 27(7), 668-675.
- Robbins SL and Cotran K (2005) Pathological basis of disease. 7th Ed. Elsevier, The Netherlands. 7(21), 1048-1050.
- Schlüter C, Duchrow M, Wohlenberg C, Becker MH, Key G, Flad HD and Gerdes J (1993) The cell proliferation-associated antigen of antibody Ki- 67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J. Cell Biol. 123(3), 513-522.
- Tamboli P, Amin MB, Schultz DS, Linden M and Kubus J (1996) Comparative analysis of the nuclear proliferative index in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma. Mod. Pathol. 9(10), 1015-1019.
- Trachtenberg J, Hicks LL and Walsh PC (l980) Androgen- and estrogen-receptor content in spontaneous and experimentally induced canine prostatic hyperplasia. J. Clin. Invest. 65, l05l-1059.
- Wright AS, Thomas LN, Douglas RC., et.al. (1996) Relative potency of testosterone and dihydrotestosterone in preventing atrophy and apoptosis in the prostate of the castrated rat. J. Clin. Invest. 98(11), 2558-2563.